In addition to atherosclerotic disease, APOE polymorphisms have been studied as factors associated with various pathological conditions such as neurodegenerative pathologies [15], diabetes [27], kidney disease [28], worse cognitive ability [29], stroke [30] and cancer [31]. This evidence concerns the gene APOE and kidney disorder.